Carregant...

Agomelatine: The evidence for its place in the treatment of depression

INTRODUCTION: Depressive disorders are among the main causes of disability due to disease. In spite of recent progress in the pharmacotherapy of depression, there is still a high nonresponse rate of ∼30% to the first antidepressant treatment. Furthermore, the latency of several weeks until sufficien...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Eser, Daniela, Baghai, Thomas C, Möller, Hans-Jürgen
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2010
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2899775/
https://ncbi.nlm.nih.gov/pubmed/20694073
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!